Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • minwei
    Registered Vendor
    • Nov 2012
    • 1

    #1

    Scientist I/II, Bioinformatics

    Scientist I/II, Bioinformatics

    Company: GENEWIZ, Inc.

    Position Type: Full-Time Employee

    Location: South Plainfield, NJ

    Responsibilities:

    Developing, implementing, and performing state-of-the-art bioinformatics analyses, applications, and workflows to grow our translational genomics and bioinformatics capabilities and infrastructure.

    Qualifications:

    • Ph.D./M.S. in Bioinformatics or related discipline;
    • Expert in next generation sequencing analysis;
    • Strong background in computation, statistics, and data analysis;;
    • Ability to address business needs with effective and efficient technical solutions;
    • Able to work independently and collaboratively in a dynamic work environment;
    • Cooperate with team members and clients from a broad range of disciplines and subject level expertise;
    • Strong communication skills, both written and verbal;
    • Demonstrate initiative in experimenting with new technologies.


    Contact Information
    GENEWIZ
    Bioinformatics
    Min Wei
    [email protected]

Latest Articles

Collapse

  • SEQadmin2
    Multiomic Liquid Biopsy: What DNA/RNA Panels Reveal That DNA Alone Can’t
    by SEQadmin2



    Tumors contain complex mixtures of cell populations that evolve in response to treatment and host-specific factors. Tissue biopsies provide only static snapshots of a tumor’s state. But what if we could follow that evolution over time using a minimally invasive technique?

    Liquid biopsies can detect tumor-derived material circulating in the bloodstream, providing a way to study treatment response, detect emerging resistance, and discover new biomarkers. Circulating
    ...
    10-14-2026, 09:55 AM
  • SEQadmin2
    New Genomics Technologies Take Aim at Long-Standing Limits
    by SEQadmin2


    Researchers using sequencing and genomics tools often have to make trade-offs. They can choose between speed or scale, short reads or long-range information, or targeted panels or a view of the whole transcriptome. New technologies that have been released this year are built to address those tough choices.

    We asked six companies the same four questions to learn about their latest products. The new technologies bring a lot to the table, including rethinking sequencing
    ...
    09-28-2026, 10:25 AM

ad_right_rmr

Collapse

News

Collapse

Topics Statistics Last Post
Started by SEQadmin2, 10-15-2026, 10:52 AM
0 responses
25 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 10-14-2026, 05:39 AM
0 responses
31 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 10-13-2026, 09:56 AM
0 responses
27 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 10-09-2026, 11:14 AM
0 responses
28 views
0 reactions
Last Post SEQadmin2  
Working...